Rosenberg Matthew Hamilton Astrazeneca PLC Transaction History
Rosenberg Matthew Hamilton
- $396 Million
- Q1 2025
A detailed history of Rosenberg Matthew Hamilton transactions in Astrazeneca PLC stock. As of the latest transaction made, Rosenberg Matthew Hamilton holds 1,228 shares of AZN stock, worth $90,663. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,228
Previous 1,135
8.19%
Holding current value
$90,663
Previous $74,000
21.62%
% of portfolio
0.02%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.21 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$3 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.63 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.35 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.31 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $229B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...